Previous 10 | Next 10 |
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- In a press release published under the same headline today by Zosano Pharma Corporation (Nasdaq:ZSAN), a measurement was incorrectly stated as grams, not micrograms. The measurements of the vaccine should have been 10μg and 15μ...
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data in an article titled, “ Immunogenicity and Safety of Inactivated Influenza Spl...
FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced changes to its board of directors, including the appointment of Elaine M. Yang. “We are pleased to welcome Elaine, a high...
FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option to purchase 220,000 shares of Zosano’s common stock to a new employee as an induc...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zosano Pharma Corporation (NASDAQ: ZSAN) Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System ” Zosano Phar...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s hot penny stocks are catching the eyes of investors and we’re diving into everything investors need to know about them on Wednesday! Source: John Brueske/Shutterstock.com Before we get onto the...
Zosano Pharma (NASDAQ:ZSAN) has gained ~12.5% in the pre-market after the company announced the successful formulation of a COVID-19 vaccine candidate using its microneedle patch system. Zosano’s patch, consisting of a range of nearly two thousand drug-coated titanium mi...
FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the successful formulation of a COVID-19 vaccine candidate, obtained from a vaccine developer, utilizing Zosano’s microneedle p...
Zosano Pharma (NASDAQ:ZSAN): Q3 GAAP EPS of -$0.07 beats by $0.01. Revenue of $0.25M beats by $0.02M. Press Release For further details see: Zosano Pharma EPS beats by $0.01, beats on revenue
FREMONT, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2021, as well as business highlights. “This quarter we made s...
News, Short Squeeze, Breakout and More Instantly...
Zosano Pharma Corporation Company Name:
ZSAN Stock Symbol:
NASDAQ Market:
Zosano Pharma Corporation Website:
FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary petition for relief under chapter 11 of title 11 (“Chapter 11”) of the United ...
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results a...